By Ryan Davis ( March 28, 2016, 7:47 PM EDT) -- On the heels of last week's jury verdict that Gilead Sciences Inc. must pay Merck & Co. Inc. $200 million in a patent case over hepatitis C drugs, Merck asked a judge Monday to award it millions more in supplemental damages and prejudgment interest....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.